$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$289.45M
Market Cap
-
P/E Ratio
-2.07
EPS
$2.59
52 Week High
$0.53
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Palisade Bio Inc. is a clinical-stage biopharmaceutical company headquartered in Carlsbad, California, dedicated to pioneering innovative therapies that protect the gastrointestinal mucosal barrier. The company focuses on developing proprietary drug candidates that tackle significant unmet needs in gastrointestinal disorders, reflecting its commitment to improving patient outcomes. With a robust emphasis on research and development, Palisade Bio is ideally positioned to enhance gastrointestinal health and drive transformative changes in treatment protocols within this vital therapeutic area. Through strategic initiatives, the company aims to deliver meaningful advancements in patient care and therapeutic effectiveness.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
IQ
TNYA
KAVL
ORCL
SOFI
PFE
ADAP
DNN
HPE
F
AAL
PLTD
KVUE
NFLX
WBD
VHAI
WULF
MARA
UGRO
RR
PLTR
BYND
VALE
BAC
SNAP
CLSK
APLT
IVP
BITF
AMD
IREN
IRBT
T
GOOGL
RIG
RKLB
QBTS
CVE
NIO
ASBP
HOOD
RGTI
CIFR
GRAB
CAN
SMR
CMG
MTSR
SOUN
JBLU
KIND
MU
HL
IBRX
NOK
AG
BTBT
APLD
CDE
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
IQ
TNYA
KAVL
ORCL
SOFI
PFE
ADAP
DNN
HPE
F
AAL
PLTD
KVUE
NFLX
WBD
VHAI
WULF
MARA
UGRO
RR
PLTR
BYND
VALE
BAC
SNAP
CLSK
APLT
IVP
BITF
AMD
IREN
IRBT
T
GOOGL
RIG
RKLB
QBTS
CVE
NIO
ASBP
HOOD
RGTI
CIFR
GRAB
CAN
SMR
CMG
MTSR
SOUN
JBLU
KIND
MU
HL
IBRX
NOK
AG
BTBT
APLD
CDE